Article thumbnail

Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans

By Frank R Sharp, Glen C Jickling, Boryana Stamova, Yingfang Tian, Xinhua Zhan, DaZhi Liu, Beth Kuczynski, Christopher D Cox and Bradley P Ander

Abstract

Whole genome expression microarrays can be used to study gene expression in blood, which comes in part from leukocytes, immature platelets, and red blood cells. Since these cells are important in the pathogenesis of stroke, RNA provides an index of these cellular responses to stroke. Our studies in rats have shown specific gene expression changes 24 hours after ischemic stroke, hemorrhage, status epilepticus, hypoxia, hypoglycemia, global ischemia, and following brief focal ischemia that simulated transient ischemic attacks in humans. Human studies show gene expression changes following ischemic stroke. These gene profiles predict a second cohort with >90% sensitivity and specificity. Gene profiles for ischemic stroke caused by large-vessel atherosclerosis and cardioembolism have been described that predict a second cohort with >85% sensitivity and specificity. Atherosclerotic genes were associated with clotting, platelets, and monocytes, and cardioembolic genes were associated with inflammation, infection, and neutrophils. These gene profiles predicted the cause of stroke in 58% of cryptogenic patients. These studies will provide diagnostic, prognostic, and therapeutic markers, and will advance our understanding of stroke in humans. New techniques to measure all coding and noncoding RNAs along with alternatively spliced transcripts will markedly advance molecular studies of human stroke

Topics: Review Article
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3137473
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). (2011b) Gender dependent correlations of carotid intima media thickness with gene expression in blood. Trans Stroke Res (in press)
  2. (2009). Cardioembolic stroke: call for a multidisciplinary approach. Cerebrovasc Dis 27(Suppl 1):82–7 Baird AE
  3. (1996). Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Rev 8:11–94 Alizadeh
  4. (2010). Clinical microfluidics for neutrophil genomics and proteomics.
  5. (2001). Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine antihuman intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32:2665–74
  6. (2008). Expert Rev Cardiovasc Ther 7:389–93
  7. (2002). Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures,
  8. (2009). Lab Anal 19:182–8 Chalela JA